Cargando…
Clinical Application of Next-Generation Sequencing of Plasma Cell-Free DNA for Genotyping Untreated Advanced Non-Small Cell Lung Cancer
SIMPLE SUMMARY: Plasma ctDNA is a material source for molecular analysis particularly useful when tissue is not available or sufficient. NGS-based plasma genotyping should be integrated into the clinical workup of newly diagnosed advanced NSCLC. ABSTRACT: Background: Analysis of circulating tumor DN...
Autores principales: | Fernandes, Maria Gabriela O., Cruz-Martins, Natália, Souto Moura, Conceição, Guimarães, Susana, Pereira Reis, Joana, Justino, Ana, Pina, Maria João, Magalhães, Adriana, Queiroga, Henrique, Machado, José Carlos, Hespanhol, Venceslau, Costa, José Luis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8199488/ https://www.ncbi.nlm.nih.gov/pubmed/34070940 http://dx.doi.org/10.3390/cancers13112707 |
Ejemplares similares
-
Liquid Biopsy for Disease Monitoring in Non-Small Cell Lung Cancer: The Link between Biology and the Clinic
por: Fernandes, Maria Gabriela O., et al.
Publicado: (2021) -
Targeted Gene Next-Generation Sequencing Panel in Patients with Advanced Lung Adenocarcinoma: Paving the Way for Clinical Implementation
por: Fernandes, Maria Gabriela O., et al.
Publicado: (2019) -
Resistance Profile of Osimertinib in Pre-treated Patients With EGFR T790M-Mutated Non-small Cell Lung Cancer
por: Fernandes, Maria Gabriela O., et al.
Publicado: (2021) -
The value of cell-free circulating tumour DNA profiling in advanced non-small cell lung cancer (NSCLC) management
por: Fernandes, Maria Gabriela O., et al.
Publicado: (2021) -
Management of Coronavirus Disease 2019 Patients With Lung Cancer: Experience From a Thoracic Oncology Center
por: Coelho, David Barros, et al.
Publicado: (2021)